Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

The global myelodysplastic syndrome treatment market is on a strong growth trajectory, set to expand at a compound ann ...

Pharma companies are “highly vulnerable” to the effects of climate change, due to their reliance on global networks. “The pharmaceutical industry is globalized: generic drugs manufactured at ...